Business Context and Reporting Period
Company: Intensity Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 4, 2025
Reporting Period: Events occurring in July 2025, with share count as of July 31, 2025.
Key Financial Metrics
This filing reports on a specific capital raising event rather than comprehensive financial performance.
- Capital Raised: Approximately $6.6 million raised in July 2025.
- Source of Funds: Sale of common stock pursuant to an At-the-Market (ATM) offering.
- Shares Outstanding: 46,035,081 shares as of July 31, 2025.
- Other Metrics: The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material change is the increase in equity capital and the corresponding increase in outstanding shares resulting from the ATM offering activity in July 2025. No other material changes to operations or financial position are detailed in this specific report.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the execution of the previously announced ATM offering. No specific forward-looking guidance, outlook, or management commentary regarding future financial performance is included in this text.
Risks and Contingencies: The filing text does not provide specific details on risks or contingencies beyond the standard disclosure of the equity issuance.
Investor Verification Checklist
- Verify the exact number of shares sold and the weighted average price per share in the attached press release (Exhibit 99.1).
- Confirm the total proceeds net of offering costs and commissions.
- Review the remaining capacity under the At-the-Market offering agreement.
- Check the company's most recent 10-Q or 10-K for updated cash balance and burn rate following this capital raise.